Alphabet's quantum spinoff starts working with AstraZeneca, Sanofi to accelerate R&D
Is this a sign that Leqembi could obtain FDA approval next month?
States back FTC in lawsuit seeking to block Amgen-Horizon deal
Sarepta prices Duchenne gene therapy at $3.2M
*please scroll down for all the latest news*
